Sign in Pull a receipt

TXMD

TherapeuticsMD, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$261.47 sample

-1.67 (-0.63%) 1D

Market cap

$1.65T

Price as of

2026-10-29

Latest filing

8-K · 2026-10-27

Alerts

8

Price$261.47 +9.02% 3M daily closessample

272.62238.04

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27SECForm 144 filed
Oct 22INSInsider sell: Chief Executive Officer
Oct 16INSInsider buy: EVP, Operations
Oct 13INSInsider buy: EVP, Operations
Oct 05SECForm 144 filed
Sep 28INSInsider buy: General Counsel
Sep 17INSInsider sell: Chief Financial Officer
Sep 14SECForm 144 filed

Sign up to see the real TXMD record →

Company facts

SEC EDGAR registration

Name: TherapeuticsMD, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: -54sample, -100 to +100
Reporting currency: USD

Who is positioning in TXMD

sample

Insiders: 14 insider transactions over 90 days, net selling, $686.8M
Congress: 2 members traded over 90 days
Institutions · 13F: 14 funds hold $16.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$37.4B +13.5% y/y

Q4 2024Q3 2026

Inventory$21.4B +10.4% y/y

Q4 2024Q3 2026

Accounts receivable$15.8B +2.2% y/y

Q4 2024Q3 2026

Total debt$45.7B +14.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $767.4B +7.7% 3M
Sample peer B: $403.4B -3.6% 3M
Sample peer C: $453.2B -1.3% 3M
Sample peer D: $610.4B +5.4% 3M
Sample peer E: $1.36T +0.5% 3M